Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

Insiders Menu
Roster
Transactions
UroGen Pharma Ltd. (URGN)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
07/25/2023Robinson James A. Jr.DirectorGrantStock Option (right to buy)20k$8.90$178k 07/25/2023
06/08/2023Schoenberg MarkChief Medical OfficerGrantRestricted Stock Units30k$0.00$0 06/08/2023
01/31/2023Schoenberg MarkChief Medical OfficerSaleOrdinary Shares248$10.12$2.5k 01/31/2023
01/31/2023Schoenberg MarkChief Medical OfficerSaleOrdinary Shares991$10.12$10k 01/31/2023
01/31/2023Schoenberg MarkChief Medical OfficerSaleOrdinary Shares661$10.12$6.7k 01/31/2023
01/31/2023Schoenberg MarkChief Medical OfficerExerciseRestricted Stock Units500$0.00$0 01/31/2023
01/31/2023Schoenberg MarkChief Medical OfficerExerciseRestricted Stock Units2k$0.00$0 01/31/2023
01/31/2023Schoenberg MarkChief Medical OfficerExerciseRestricted Stock Units1.3k$0.00$0 01/31/2023
01/31/2023Schoenberg MarkChief Medical OfficerGrantRestricted Stock Units10k$0.00$0 01/31/2023
01/31/2023Schoenberg MarkChief Medical OfficerGrantEmployee Stock Option (right to buy)30k$10.39$311.7k 01/31/2023
01/31/2023Smith Jason DrewGeneral CounselSaleOrdinary Shares409$10.12$4.1k 01/31/2023
01/31/2023Smith Jason DrewGeneral CounselSaleOrdinary Shares1.2k$10.12$12.4k 01/31/2023
01/31/2023Smith Jason DrewGeneral CounselExerciseRestricted Stock Units833$0.00$0 01/31/2023
01/31/2023Smith Jason DrewGeneral CounselExerciseRestricted Stock Units2.5k$0.00$0 01/31/2023
01/31/2023Smith Jason DrewGeneral CounselGrantRestricted Stock Units20k$0.00$0 01/31/2023
01/31/2023Smith Jason DrewGeneral CounselGrantEmployee Stock Option (right to buy)40k$10.39$415.6k 01/31/2023
01/31/2023Barrett Elizabeth A.CEOExerciseRestricted Stock Units5k$0.00$0 01/31/2023
01/31/2023Barrett Elizabeth A.CEOExerciseRestricted Stock Units13.3k$0.00$0 01/31/2023
01/31/2023Barrett Elizabeth A.CEOGrantRestricted Stock Units75k$0.00$0 01/31/2023
01/31/2023Barrett Elizabeth A.CEOGrantEmployee Stock Option (right to buy)125k$10.39$1.3M 01/31/2023
01/31/2023Barrett Elizabeth A.CEOGrantPerformance Stock Units100k$0.00$0 01/31/2023
01/20/2023Schoenberg MarkChief Medical OfficerExerciseEmployee Stock Option (right to buy)122.7k$5.00$613.4k 01/20/2023
11/08/2022Wildman Daniel GeorgeDirectorGrantStock Option (right to buy)20k$11.88$237.6k 11/08/2022
10/21/2022Nussbaum RanDirectorExerciseStock Option (right to buy)32.7k$5.94$194.4kBy Pontifax (Israel) III Limited Partnership10/21/2022
10/21/2022Nussbaum RanDirectorExerciseStock Option (right to buy)15.3k$5.94$90.7kBy Pontifax Cayman III Limited Partnership10/21/2022
09/14/2022Belldegrun ArieDirectorExerciseStock Option (right to buy)160k$5.00$800k 09/14/2022
09/08/2022WEN LEANADirectorGrantStock Option (right to buy)20k$7.73$154.6k 09/08/2022
08/31/2022Smith Jason DrewGeneral CounselSaleOrdinary Shares3.6k$7.21$26k 08/31/2022
08/31/2022Smith Jason DrewGeneral CounselExerciseRestricted Stock Units8.3k$0.00$0 08/31/2022
08/31/2022Belldegrun ArieDirectorExerciseStock Option (right to buy)3.2k$5.00$16.2k 08/31/2022
08/01/2022Schoenberg MarkChief Medical OfficerSaleOrdinary Shares259$7.81$2k 07/31/2022
07/31/2022Schoenberg MarkChief Medical OfficerExerciseRestricted Stock Units500$0.00$0 07/31/2022
06/16/2022Nussbaum RanDirectorExerciseStock Option (right to buy)2.2k$5.00$11.1kBy Pontifax (Israel) III Limited Partnership06/16/2022
06/08/2022Nussbaum RanDirectorGrantStock Option (right to buy)6.8k$7.06$48.1kby Pontifax (Israel) III Limited Partnership06/08/2022
06/08/2022Nussbaum RanDirectorGrantStock Option (right to buy)3.2k$7.06$22.5kBy Pontifax Cayman III Limited Partnership06/08/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy